A Positron Emission Tomography Study to Assess Binding of Lecozotan, a Novel 5-Hydroxytryptamine-1A Silent Antagonist, to Brain 5-HT1A Receptors in Healthy Young and Elderly Subjects, and in Patients With Alzheimer's Disease
2007 ◽
Vol 83
(1)
◽
pp. 86-96
◽
2000 ◽
Vol 48
(2)
◽
pp. 194-200
◽
Microglial activation in Alzheimer's disease: an (R)-[11C]PK11195 positron emission tomography study
2013 ◽
Vol 34
(1)
◽
pp. 128-136
◽
1995 ◽
Vol 10
(4)
◽
pp. 403-403
◽
2000 ◽
Vol 31
(2)
◽
pp. 147-158
◽